Salbutamol for transient tachypnea of the newborn.

CONCLUSIONS: At present there is insufficient evidence to determine the efficacy and safety of salbutamol in the management of transient tachypnea of the newborn. The quality of evidence was low due to paucity of included trials, small sample sizes and overall poor methodologic quality.
PMID: 27210618 [PubMed - as supplied by publisher]

Source: Cochrane Database of Systematic Reviews - May 22, 2016 Category: Journals (General) Authors: Moresco L, Bruschettini M, Cohen A, Gaiero A, Calevo MG Tags: Cochrane Database Syst Rev Source Type: research